gas

(redirected from GALNS)
Also found in: Dictionary, Medical, Legal, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • all
  • noun
  • verb

Synonyms for gas

fumes

Synonyms

petrol

Synonyms for gas

something or someone uproariously funny or absurd

to talk volubly, persistently, and usually inconsequentially

Synonyms for gas

the state of matter distinguished from the solid and liquid states by: relatively low density and viscosity

a volatile flammable mixture of hydrocarbons (hexane and heptane and octane etc.) derived from petroleum

a state of excessive gas in the alimentary canal

a fossil fuel in the gaseous state

Synonyms

Related Words

attack with gas

Related Words

References in periodicals archive ?
Assay-optimization experiments revealed a maximum GALNS activity at pH 4.
Use of the GALNS assay with liquid-phase extraction demonstrated that the enzyme activity in DBSs from 9 MPS-IVA patients (range, 0.
4] Nonstandard abbreviations: MPS-IVA, mucopolysaccharidosis type IVA; GALNS, N-acetylgalactosamlne-6-sulfate sulfatase; ESI-MS/MS, electrospray ionization--tandem mass spectrometry; DBS, dried blood spot; GALNS-S, GALNS substrate; GALNS-IS, GALNS internal standard; GALNS-P, GALNS product.
Como se observo en el perfil de actividad enzimatica, las celulas HEK293 presentaron niveles basales de ARNm GALNS.
La cotransfeccion con AAVSUMF1 en una relacion 1:1 produjo un incremento en la actividad GALNS de 2,4 veces (p<0,01), con respecto a las celulas transfectadas sin CMVSUMF1 (figura 4A).
The primary goal of the open-label, multinational clinical study is to assess the safety and tolerability of infusions of GALNS at a dose of 2.
According to the company, GALNS or BMN-110 (N-acetylgalactosamine 6-sulfatase) trial is being initiated for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), also called Morquio A Syndrome.
It is a major milestone in the GALNS programme to have 176 patients randomised and dosed at 31 sites in 17 countries worldwide.
Biopharmaceuticals company BioMarin Pharmaceutical Inc (Nasdaq:BMRN) reported on Tuesday the initiation of a Phase 2 trial of GALNS in patients with mucopolysaccharidosis IVA (MPS IVA).
The company added the primary objective of the Phase 2, open-label, multinational clinical study is to evaluate the safety and tolerability of infusions of GALNS (N-acetylgalactosamine 6-sulfatase) at a dose of 2.